These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15757459)

  • 1. Therapies for HIV and viral hepatitis coinfection.
    Cooper CL
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):81-9. PubMed ID: 15757459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
    Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
    Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
    Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir-based antiretroviral therapy in 
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
    Boettiger DC; Kerr S; Ditangco R; Chaiwarith R; Li PC; Merati TP; Pham TT; Kiertiburanakul S; Kumarasamy N; Vonthanak S; Lee CK; Van Kinh N; Pujari S; Wong WW; Kamarulzaman A; Zhang F; Yunihastuti E; Choi JY; Oka S; Ng OT; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Law M;
    Antivir Ther; 2016; 21(1):27-35. PubMed ID: 26069150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
    Lincoln D; Petoumenos K; Dore GJ;
    HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatitis B in patients coinfected with the human immunodeficiency virus.
    Lessells R; Leen C
    Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):366-74. PubMed ID: 15112069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
    Huang YS; Chang SY; Sheng WH; Sun HY; Lee KY; Chuang YC; Su YC; Liu WC; Hung CC; Chang SC
    PLoS One; 2016; 11(12):e0169228. PubMed ID: 28033344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
    Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV and viral hepatitis coinfection: specificities].
    Piroth L
    Rev Prat; 2011 Jan; 61(1):65-7. PubMed ID: 21452546
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus and HIV infection.
    Martín-Carbonero L; Poveda E
    Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.
    Soriano V; de Mendoza C; Peña JM; Barreiro P
    Expert Opin Pharmacother; 2015 Feb; 16(2):179-86. PubMed ID: 25529507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights of the third international workshop on HIV and hepatitis coinfection.
    Vogel M; Rockstroh J
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):769-71. PubMed ID: 17914911
    [No Abstract]   [Full Text] [Related]  

  • 20. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.